These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11850381)

  • 21. What you don't know will hurt you.
    Nat Biotechnol; 2008 Jun; 26(6):589. PubMed ID: 18536658
    [No Abstract]   [Full Text] [Related]  

  • 22. Post-marketing strategies for medicines.
    Breckenridge A
    Clin Pharmacol Ther; 2008 Jan; 83(1):24-5; discussion 25. PubMed ID: 18043682
    [No Abstract]   [Full Text] [Related]  

  • 23. Canaries, coal mines and the drug supply.
    Leiden JM
    Nat Biotechnol; 2008 Jun; 26(6):624-6. PubMed ID: 18536681
    [No Abstract]   [Full Text] [Related]  

  • 24. OTC article makes headlines.
    Wasserman GS; Montgomery EJ
    Mo Med; 2009; 106(1):32. PubMed ID: 19248243
    [No Abstract]   [Full Text] [Related]  

  • 25. Acetaminophen: old friend--new rules.
    Turkoski BB
    Orthop Nurs; 2010; 29(1):41-3; quiz 44-5. PubMed ID: 20142694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What you should know about FDA-USP Drug Product Problem Reporting Program.
    McGinnis DM
    Pharm Times; 1986 Apr; 52(4):101-4, 109. PubMed ID: 10276472
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA works to reduce preventable medical device injuries.
    Rados C
    FDA Consum; 2003; 37(4):29-33. PubMed ID: 12971346
    [No Abstract]   [Full Text] [Related]  

  • 28. 2D matrix codes and machine vision ensure traceability.
    Simpson L
    Med Device Technol; 2003 May; 14(4):48. PubMed ID: 12774580
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post marketing surveillance of new drugs. Patient safety in the hands of GPs.
    Marley JE
    Aust Fam Physician; 1989 Sep; 18(9):1133-5. PubMed ID: 2590077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulatory issues of biologically active supplements in Armenia].
    Gabrielian ES; Amroian EA; Zakarian AA; Osipian LL; Pogosian UG
    Vopr Pitan; 2003; 72(1):27-9. PubMed ID: 12664696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postmarketing surveillance studies in community pharmacies].
    Nieber K; Lehmacher W
    Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encoding technical information in GM organisms.
    Marillonnet S; Klimyuk V; Gleba Y
    Nat Biotechnol; 2003 Mar; 21(3):224-6. PubMed ID: 12610560
    [No Abstract]   [Full Text] [Related]  

  • 34. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What has been happening with over-the-counter drug regulation.
    Stringer S
    Food Drug Law J; 1998; 53(4):633-41. PubMed ID: 10557581
    [No Abstract]   [Full Text] [Related]  

  • 36. Identity tags.
    Pauli U
    Nat Biotechnol; 2003 Jun; 21(6):598. PubMed ID: 12776138
    [No Abstract]   [Full Text] [Related]  

  • 37. Identity tags revisited.
    Marillonnet S; Klimyuk V; Gleba Y
    Nat Biotechnol; 2003 Sep; 21(9):974-5; author reply 975. PubMed ID: 12949551
    [No Abstract]   [Full Text] [Related]  

  • 38. Making 'safety first' a reality for biotechnology products.
    Kapuscinski AR; Goodman RM; Hann SD; Jacobs LR; Pullins EE; Johnson CS; Kinsey JD; Krall RL; La Viña AG; Mellon MG; Ruttan VW
    Nat Biotechnol; 2003 Jun; 21(6):599-601. PubMed ID: 12776139
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmarket surveillance for medical devices: America's new strategy.
    Normand SL; Hatfield L; Drozda J; Resnic FS
    BMJ; 2012 Oct; 345():e6848. PubMed ID: 23060660
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of over-the-counter hydroquinone bleaching creams.
    Brauer EW
    Arch Dermatol; 1985 Oct; 121(10):1239. PubMed ID: 4037812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.